Merck & Co., Inc. is 170.9x more valuable than Nanobiotix S.A. by market capitalization ($294.03 B vs $1.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NBTX | MRK |
|---|---|---|
| Market cap | $1.72 B | $294.03 B |
| US-listed rank | #2224 | #45 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | - | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 295 | 996 |
Merck & Co., Inc. is 170.9x more valuable than Nanobiotix S.A. by market capitalization ($294.03 B vs $1.72 B).
Full pages: Nanobiotix S.A. and Merck & Co., Inc., or browse the full rankings.